← Today’s ReceiptsSource pending
Public-record receiptR-ALSource pending
Tommy Tuberville disclosed SELL $AMGN
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2025-05-16
Trade date
2025-04-15
Disclosure lag
31 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 31 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
49 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Tommy Tuberville, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 28 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-05-16 · disclosed 31d after transaction
Market context
Amgen Inc.
Sector: Healthcare
Factual flags
- 28 lobbying filings linked to this ticker.
- 9 nearby same-ticker disclosures in the surrounding 30-day window.
- 4 healthcare,pharma / biotech sector trades within 30 days while on relevant committee
- Traded AMGN 6d before lobbying filing by AMGEN INC ($3,610,000) (committee overlap: Healthcare)
- 15 trades filed on 2025-05-16 (batch dump)
- 4 members traded AMGN within 7 days (starting 2025-04-08)
- Sits on committee with jurisdiction over healthcare/pharma/biotech sector — traded AMGN on 2025-04-15
Member trail
Tommy Tuberville
U.S. Senate · AL
Senate Committee on AgricultureNutritionand ForestrySenate Committee on Armed ServicesSenate Committee on HealthEducation
Ticker trail
$AMGN
Amgen Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.